Skip to Content Skip to Navigation

Over ons Praktische zaken Waar vindt u ons A. Visser

University Medical Center Groningen

A. Visser

Profielfoto van A. Visser

Faculteit Medische Wetenschappen/UMCG

Telefoon:

E-mail:

l.visser umcg.nl

ORCID Research Portal

Research interests

Lydia Visser received a PhD from the University of Groningen, the Netherlands in 2000 on her thesis titled: ‘Antibodies against leucocyte common antigen (CD45)-applications in immunomodulation’. She subsequently held a post-doctoral position at the Robards Research Institute of the University of Western Ontario in London (Ontario, Canada) on a project on the mechanism of anti-CD45RB tolerance induction. She is currently working at the department of Pathology and Medical Biology of the University Medical center Groningen as a scientist. She is as a PI part of the SALL. Her research is mainly focussed on the immunology of lymphoma and consists of interactions of tumor cells with the micro environment and signalling pathways in Hodgkin lymphoma and non-Hodgkin lymphomas.

Publicaties

Novel inhibitors of aspartate transcarbamoylase (atcase) and compositions, methods and uses related thereto

Groves, M. R., Wang, C., Lunev, S., Zhang, B., Dömling, A. S. S. & Visser, A., 8-jun.-2023, Octrooi Nr. WO2023101556, 2-dec.-2022, Prioriteitsdatum 2-dec.-2021

Onderzoeksoutput

TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia

Burg, M. M. L., Visser, L. & Diepstra, A., 12-dec.-2023, (E-pub ahead of print) In: Histopathology.

Onderzoeksoutput › › peer review

Toxic Determination of Cry11 Mutated Proteins Obtained Using Rational Design and Its Computational Analysis

Suárez-Barrera, M. O., Herrera-Pineda, D. F., Rondón-Villarreal, P., Pinzón-Reyes, E. H., Ochoa, R., Visser, L. & Rueda-Forero, N. J., 22-mei-2023, In: International Journal of Molecular Sciences. 24, 10, 13 blz., 9079.

Onderzoeksoutput › › peer review

A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Johnston, R. L., Mottok, A., Chan, F. C., Jiang, A., Diepstra, A., Visser, L., Telenius, A., Gascoyne, R. D., Friedman, D. L., Schwartz, C. L., Kelly, K. M., Scott, D. W., Horton, T. M. & Steidl, C., 10-feb.-2022, In: Blood. 139, 6, blz. 889-893 5 blz.

Onderzoeksoutput › › peer review

Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro

Malenge, M. M., Maaland, A. F., Repetto-Llamazares, A., Middleton, B., Nijland, M., Visser, L., Patzke, S., Heyerdahl, H., Kolstad, A., Stokke, T., Ree, A. H. & Dahle, J., 29-apr.-2022, In: PLoS ONE. 17, 4, 22 blz., e0267543.

Onderzoeksoutput › › peer review

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma

Veldman, J., Placa, J. R., Chong, L., Terpstra, M. M., Mastik, M., van Kempen, L. C., Kok, K., Aoki, T., Steidl, C., van den Berg, A., Visser, L. & Diepstra, A., 31-dec.-2022, In: OncoImmunology. 11, 1, 11 blz., 2033433.

Onderzoeksoutput › › peer review

Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway

Mo, H-Y., Wei, Q-Y., Zhong, Q-H., Zhao, X-Y., Guo, D., Han, J., Noracharttiyapot, W., Visser, L., van den Berg, A., Xu, Y-M. & Lau, A. T. Y., 16-jul.-2022, In: International Journal of Molecular Sciences. 23, 14, 22 blz., 7853.

Onderzoeksoutput › › peer review

Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials

Wang, C., Zhang, B., Krüger, A., Du, X., Visser, L., Dömling, A., Wrenger, C. & Groves, M., 19-okt.-2022, In: Journal of the American Chemical Society. 144, 41, blz. 19070–19077 8 blz.

Onderzoeksoutput › › peer review

Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

Langendonk, M., de Jong, M. R. W., Smit, N., Seiler, J., Reitsma, B., Ammatuna, E., Glaudemans, A. W. J. M., van den Berg, A., Huls, G. A., Visser, L. & van Meerten, T., 7-mrt.-2022, In: Blood cancer journal. 12, 3, 9 blz., 36.

Onderzoeksoutput › › peer review

Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma

Langendonk, M., Smit, N. A. M., Plattel, W., Diepstra, A., Meerten, T. V. & Visser, L., nov.-2022, In: International Journal of Molecular Sciences. 23, 22, 12 blz., 13751.

Onderzoeksoutput › › peer review

Alle (156) publicaties

Bekijk volledig onderzoeksprofiel

Volg de RUGfacebook twitter linkedin rss instagram youtube